1 August 2006
SMITHS Medical, part of the global engineering business Smiths Group, announced today it has launched a new range of advanced embryo replacement catheters in response to the changing needs of fertility specialists.
The Sure-Pro and Sure-Pro Ultra catheters, which will be used for in-vitro fertilisation procedures, are the result of research by Smiths Medical into the changing needs of its customers.
The new range was showcased in June at National Infertility Day - a patient awareness event in London. Patients said they liked the idea that they could see their embryos being released thanks to the Sure-Pro Ultra catheter, which is visible under ultrasound.
Smiths Medical is the global market leader in embryo transfer products consistently striving to innovate its range and offer advanced fertility solutions to its customers.
ENDS
General media enquiries
Contact our global media and communications team at:
Please note – the press team can only answer enquiries from accredited members of the press.
Related articles
Smiths announces key geothermal win in its John Crane business
Read our latest company news as John Crane marks a significant geothermal win helping accelerate the delivery of clean, reliable power in the United States
Find out more
Smiths celebrates 175 years of engineering excellence
Read our latest company news as Smiths celebrates its 175th anniversary in 2026.
Find out more
Smiths Group’s John Crane business announces key H1 2026 customer wins
Read the latest news from Smiths, as John Crane announces key H1 2026 customer wins
Find out more
